Clearmind Medicine issues $2.7 million convertible notes at 90% of face value
Share
Listen to the news
Clearmind Medicine issues $2.7 million convertible notes at 90% of face value
  • Clearmind Medicine entered securities purchase agreements on Sept. 17, 2025 to issue up to USD 10 million of convertible promissory notes.
  • An agreement announced April 20, 2026 provided for USD 2.7 million of convertible promissory notes sold for USD 2.43 million in cash.
  • CLA Investors converted USD 2.68 million of promissory notes on April 21, 2026 into 4,466,716 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-045863), on April 21, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending